{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:55:55Z","timestamp":1784800555809,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian Agencies: Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.colsurfb.2016.05.065","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T21:17:33Z","timestamp":1464297453000},"page":"748-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessment"],"prefix":"10.1016","volume":"145","author":[{"given":"Simone M.","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana R.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiane","family":"Roversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcia G.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra K.S.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda M.","family":"Piegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo J.","family":"Freddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Dalla","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilise E.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia M.","family":"Colom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2016.05.065_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4088\/JCP.10r06264yel","article-title":"Past and present progress in the pharmacologic treatment of schizophrenia","volume":"71","author":"Kane","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0010","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/17460441.2013.821108","article-title":"Novel approaches to drug design for the treatment of schizophrenia","volume":"8","author":"Taly","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/10837450.2013.829094","article-title":"Development of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 2(3) full-factorial design","volume":"19","author":"Haas","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31887\/DCNS.2010.12.3\/jkane","article-title":"Pharmacologic treatment of schizophrenia","volume":"12","author":"Kane","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0030","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1517\/14656566.2012.709235","article-title":"Clozapine for the treatment of schizophrenia","volume":"13","author":"Fakra","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/appi.neuropsych.13110335","article-title":"Pharmacological management of persistent hostility and aggression in persons with schizophrenia spectrum disorders: a systematic review","volume":"26","author":"Victoroff","year":"2014","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2008.06.088","article-title":"Clozapine-induced myocarditis: role of catecholamines in a murine model","volume":"592","author":"Wang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0045","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/S0142-9612(01)00043-6","article-title":"Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules","volume":"22","author":"Mosqueira","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0050","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1023\/A:1012248721523","article-title":"Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density","volume":"18","author":"Mosqueira","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2011.01.061","article-title":"Preparation and characterization of polymeric pH-sensitive STEALTH(R) nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel","volume":"408","author":"Lundberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2015.04.054","article-title":"In vitro and in vivo evaluation of delta(9)-tetrahidrocannabinol\/PLGA nanoparticles for cancer chemotherapy","volume":"487","author":"Martin-Banderas","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood-brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuint.2012.06.015","article-title":"Haloperidol-loaded polysorbate-coated polymeric nanocapsules decrease its adverse motor side effects and oxidative stress markers in rats","volume":"61","author":"Benvegnu","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11011-014-9621-5","article-title":"Clozapine linked to nanocapsules minimizes tissue and oxidative damage to biomolecules lipids, proteins and DNA in brain of rats Wistar","volume":"30","author":"da Costa Gullich","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2009.09.004","article-title":"Biodegradation, biodistribution and toxicity of chitosan","volume":"62","author":"Kean","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jconrel.2006.06.011","article-title":"Uptake studies in rat Peyer\u2019s patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination","volume":"114","author":"Borges","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.carbpol.2013.01.072","article-title":"A comparative study of chitosan shielding effect on nano-carriers hydrophilicity and biodistribution","volume":"94","author":"Ishak","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0095","first-page":"1","article-title":"Clozapine-loaded polysorbate-coated polymeric. nanocapsules: physico-chemical characterization and toxicity evaluation in caenorhabditis elegans model","volume":"15","author":"Moraes","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0100","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1166\/jnn.2011.3521","article-title":"Simultaneous control of capsaicinoids release from polymeric nanocapsules","volume":"11","author":"Contri","year":"2011","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0105","unstructured":"C.N.d.C.d.E.A. CONCEA, Diretriz Brasileira para o cuidado e a utiliza\u00e7\u00e3o de animais para fins cient\u00edficos e did\u00e1ticos\u2212DBCA, in: Bras\u00edlia-DF (Ed.), BRASIL. Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o. Conselho Nacional de Controle de Experimenta\u00e7\u00e3o Animal -CONCEA, (2013)."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0110","unstructured":"C.C.A. Care, Guide to the Care and Use of experimental Animals, (1993)."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2010.12.016","article-title":"Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats","volume":"77","author":"Benvegnu","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF02247125","article-title":"D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine","volume":"102","author":"Ujike","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(00)00277-6","article-title":"Intravenous and oral clozapine pharmacokinetics, pharmacodynamics, and concentration-effect relations: acute tolerance","volume":"398","author":"Sun","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0130","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/10826076.2011.639118","article-title":"A highly sensitive LC-MS\/MS method for the determination of clozapine in rat plasma: application to a pre-clinical pharmacokinetic study","volume":"35","author":"Haas","year":"2012","journal-title":"J. Liquid Chromatog. Related Technol.s"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0135","series-title":"Applied Biopharmaceutics and Pharmacokinetics","author":"Shargel","year":"2012"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0140","first-page":"0","article-title":"Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice","author":"Goi","year":"2015","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2012.01.051","article-title":"Hemocompatibility of poly(varepsilon-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan","volume":"426","author":"Bender","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0150","unstructured":"H.D. Fessi J-Ph., Puisieux F., Proc\u00e9d\u00e9 de pr\u00e9paration d\u00eas syst\u00e9mes colloidaux dispersibles d\u2019une substancesous forme de nanocapsules. European Patent, in: A1 (Ed.) (1988)."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","article-title":"Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo","volume":"34","author":"Haas","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0160","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1166\/jnn.2010.1920","article-title":"Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability","volume":"10","author":"Fontana","year":"2010","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jbn.2015.2082","article-title":"Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats","volume":"11","author":"Dimer","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0170","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1166\/jnn.2006.444","article-title":"Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine","volume":"6","author":"Mosqueira","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejps.2009.11.002","article-title":"Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes","volume":"39","author":"Kadiyala","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0180","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2006.01.035","article-title":"Diffusion and mathematical modeling of release profiles from nanocarriers","volume":"313","author":"Cruz","year":"2006","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.colsurfb.2015.12.044","article-title":"Encapsulation of clozapine in polymeric nanocapsules and its biological effects","volume":"140","author":"Lukasiewicz","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0190","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","article-title":"Chitosan and chitosan\/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines","volume":"14","author":"Calvo","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0200","unstructured":"DrugFuture http:\/\/www.drugfuture.com\/chemdata\/clozapine.html (2014)."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0210","first-page":"198","article-title":"R\u00e9culas secas contendo F\u00e1rmaco modelo lipof\u00edlico preparadas a partir de suspens\u00e3o aquosa: estudo de formula\u00e7\u00e3o","volume":"25","author":"Pereira","year":"2006","journal-title":"Latin Am. J. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1166\/jbn.2009.1030","article-title":"Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system","volume":"5","author":"Fontana","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0220","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0142-9612(02)00377-0","article-title":"Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin","volume":"24","author":"Cai","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nano.2008.12.003","article-title":"PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation","volume":"5","author":"Muthu","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0230","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1166\/jbn.2014.1817","article-title":"Nanoencapsulation of olanzapine increases its efficacy in antipsychotic treatment and reduces adverse effects","volume":"10","author":"Dimer","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0235","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1021\/acs.molpharmaceut.5b00875","article-title":"Pharmacokinetic investigation of quetiapine transport across blood-Brain barrier mediated by lipid core nanocapsules using brain microdialysis in rats","volume":"13","author":"Carreno","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i2.10","article-title":"Nanocapsule technology: a review","volume":"19","author":"Couvreur","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0250","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1248\/bpb.b12-00769","article-title":"The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia\/reperfusion injury","volume":"36","author":"Zhao","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0255","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejpb.2013.08.011","article-title":"Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration","volume":"85","author":"Martins","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0260","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.2147\/IJN.S34301","article-title":"Modification of polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery","volume":"7","author":"Fang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejpb.2012.11.030","article-title":"Adsorption of plasma proteins on uncoated PLGA nanoparticles","volume":"85","author":"Sempf","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0270","doi-asserted-by":"crossref","first-page":"8178","DOI":"10.1021\/la060951b","article-title":"Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)","volume":"22","author":"Zahr","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0275","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/mp2005615","article-title":"Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery","volume":"9","author":"Amoozgar","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0280","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.biomaterials.2004.04.006","article-title":"Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles","volume":"26","author":"Chellat","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0285","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10856-008-3621-0","article-title":"Effects of alkylated-chitosan-DNA nanoparticles on the function of macrophages","volume":"20","author":"Liu","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.colsurfb.2016.05.065_bib0290","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine (Lond)"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516304015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776516304015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T18:17:27Z","timestamp":1656613047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776516304015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"alternative-id":["S0927776516304015"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.065","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessment","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}